Email
Password
Remember meForgot password?
    Log in with Twitter

article imageGlaxoSmithKline asks for regulatory approval of malaria vaccine

By Walter McDaniel     Jul 24, 2014 in Health
Researchers at GlaxoSmithKline believe they have finally developed an effective vaccine for Malaria. Now they need government approval to finish and deploy the latest version.
Early studies are promising as test cases have shown halved rates of infection. After many more tests manufacturers seek regulatory approval in the United Kingdom.
Plans are to release the vaccine in multiple African countries and you can see a list of them at the bottom of this article. Vaccines have so far been accepted fairly well in many African countries although there has been some opposition from Nigerian Muslims. Defeating Malaria in Africa is a major issue both for internal governments and international organizations.
GlaxoSmithKline executives have made attempts to spread AIDS drugs to "desperately sick" patients. South Africa factually has a problem with AIDS and certain reports confirm that drugs have helped increase average life expectancy.
While many sites have praised their work in third world countries not everything is perfect at GlaxoSmithKline. Company branches and officials are under investigation for their involvement in Chinese hospital corruption. Safety in other sectors is also being proved due to the death of 37-year-old man at their Waterford plant.
Vaccine development itself is heading along at a steady pace after funding from the Bill & Melinda Gates Foundation. GlaxoSmithKline researchers now have the funding and equipment needed to finish the vaccine. As with any vaccine UK officials will need to give final approval before any shots are distributed.
More about Vaccines, drugmakers, Glaxosmithkline, Bill gates
More news from Show all 8